8-K

Odysight.ai Inc. (ODYS)

8-K 2025-08-13 For: 2025-08-13
View Original
Added on April 07, 2026

UNITED STATES

SECURITIES AND

EXCHANGE COMMISSION

Washington, D.C.

20549

FORM 8-K

CURRENT

REPORT

Pursuant

to Section 13 OR 15(d)

of The

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):August 13, 2025

ODYSIGHT.AI INC.

(Exact name of registrant as specified in itscharter)

Nevada 001-42497 47-4257143
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
Suite 7A, Industrial Park<br><br> <br>P.O. Box 3030, Omer, Israel 8496500
--- ---
(Address of principal executive offices) (Zip Code)

+972 73 370-4690

(Registrant’s telephone number, includingarea code)

Not Applicable

(Former name or former address, if changed sincelast report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.001 par value per share ODYS Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and FinancialCondition.

On August 13, 2025, Odysight.ai, Inc. (the “Company”) issued a press release announcing financial results for the first half of 2025 and providing a business update. The press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

The information in this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Number Description
99.1 Press release dated August 13, 2025
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
| 2 |

| --- |

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ODYSIGHT.AI INC.
Date: August 13, 2025 By: /s/ Einav Brenner
Name: Einav Brenner
Title: Chief Financial Officer
| 3 |

| --- |

Exhibit 99.1

Odysight.ai ReportsFinancial Results for The First Half of 2025 and Provides Business Update

OMER, Israel, August 13, 2025 – Odysight.ai Inc. (NASDAQ: ODYS), a leading provider of visual based predictive maintenance (PdM) and condition-based monitoring (CBM) solutions, announces its financial results for the first half of 2025 and provides a business update.

Key highlights for the six months endedJune 30,2025

Revenue of $2.4 million.
Net cash position***^1^*** of approximately $33.2 million as of June 30, 2025.
--- ---
Uplisted to the Nasdaq Capital Markets; added to the Russell Microcap® Index.
--- ---
Strengthened global presence with commercial achievements:
--- ---
- Delivered system for the Heron TP UAV platform with Israeli ministry of defense (MOD) and Israeli Air Force (IAF).
--- ---
- Signed a strategic partnership with a multinational technology group to integrate Odysights’s<br>predictive health monitoring (PHM) system on several platforms.
--- ---
- Received a PO from a European partner for an industrial solution to be deployed in various industrial sectors such as cranes, elevators<br>and transportation systems.
--- ---
- Partnered with Israel Railways to deploy Odysight’s PHM system to prevent derailments and enhance railway safety.
--- ---

Einav Brenner, Chief Financial Officer of Odysight.ai:During the second quarter, we deepened our partnerships with tier-one customers and advanced the development and integrationof our predictive maintenance system, which monitors critical conditions across key industrial sectors. This supports our ongoing transitiontoward the aerospace and defense sectors, a shift initiated last year that may lead to short-term fluctuations in our quarterly revenues.We are proud our system was selected for deployment on the Heron TP - a Medium Altitude Long Endurance (MALE) unmanned aerial vehicle(UAV) and a strategic asset to the Israeli Ministry of Defense and Air Force. We also signed an agreement with a multinational technologygroup operating in defense, mining, agriculture and autonomous vehicles. This collaboration strengthens our partner’s global positionas a leader in critical systems and marks a key milestone in expanding our predictive maintenance technology beyond aviation. As we scaleinitial orders and lay the groundwork for broader global collaborations, we are encouraged by the strong technological performance ofour solutions and optimistic that early traction will translate into financial results.


Financial highlights for the six monthsended June 30, 2025

Revenues were approximately $2.4 million, compared to $1.4 million from the six months ended June 30, 2024. The increase was primarily attributed to the full recognition of approximately $1.7 million in revenues from the fulfillment of a contract with a Fortune 500 medical company and to an increase in revenues from our vision-based platform solutions for PdM and CBM.

***Backlog^2^***was approximately $14.4 million as of June 30, 2025.

Cost of Revenues was $1.8 million, compared to $1.1 million for the six months ended June 30, 2024. The increase was primarily attributed to approximately $1.0 million in cost of revenues related to the fulfillment of a contract with a Fortune 500 medical company, to the recognition of an inventory impairment of $0.2 million, and to an increase in revenues from our vision-based platform solutions for PdM and CBM.

Gross Profit was $0.7 million, reflecting a gross margin of approximately 28%, compared to gross profit of $0.3 million and gross margin of approximately 21%, for the six months ended June 30, 2024.

^1^Including cash, cash equivalentsand restricted cash.

^2^Backlog is measured and defineddifferently by companies within our industry. We refer to “backlog” as our booked orders based on purchase orders or hardcommitments but not yet recognized as revenue. Backlog is not a comprehensive indicator of future revenue and is not a measure of profitability.Orders included in backlog may be cancelled or rescheduled by customers. A variety of conditions, both specific to the individual customerand generally affecting the customer’s industry, may cause customers to cancel, reduce or delay orders that were previously madeor anticipated. Projects may remain in backlog for extended periods of time.

Operating expenseswere $9.7 million, compared to $6.0 million for the six months ended June 30, 2024. The increase was primarily driven by the expansion of the Company’s operations, including the development of new Industry 4.0 products, efforts to penetrate new markets and enhance product visibility, as well as one-time expenses related to the Company’s uplisting to Nasdaq.

Net loss was $8.3 million, compared to $5.3 million for the six months ended June 30, 2024.

Cash Balance*^1^* as of June 30, 2025 was $33.2 million, compared to approximately $13.6 million as of June 30, 2024. In February 2025, the Company uplisted to the Nasdaq Capital Market and completed a U.S. underwritten public offering with gross proceeds of approximately $23.7 million.

Financial highlights for three months endedJune 30, 2025

Revenues were approximately $0.4 million, compared to $1.2 million from the three months ended June 30, 2024. The decrease in revenues was primarily attributable to the decrease in revenues from the Fortune 500 medical company customer.

Cost of Revenues was $0.2 million, compared to $0.7 million for the three months ended June 30, 2024. The decrease was primarily attributed to the decrease in delivery to the Fortune 500 medical company customer.

Gross Profit was $0.1 million, reflecting a gross margin of 37%, compared to gross profit of $0.5 million and gross margin of approximately 44%, for the three months ended June 30, 2024.

Operating expenseswere $4.6 million, compared to $2.9 million for the three months ended June 30, 2024. The increase was primarily driven by the expansion of the Company’s operations, including the development of new Industry 4.0 products, efforts to penetrate new markets and enhance product visibility

Net loss was $4.1 million, compared to $2.2 million for the three months ended June 30, 2024.

About Odysight.ai

Odysight.ai is pioneering the Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) markets with its visualization and AI platform. Providing video sensor-based solutions for critical systems in the aviation, transportation, and energy industries, Odysight.ai leverages proven visual technologies and products from the medical industry. Odysight.ai’s unique video-based sensors, embedded software, and AI algorithms are being deployed in hard-to-reach locations and harsh environments across a variety of PdM and CBM use cases. Odysight.ai’s platform allows maintenance and operations teams visibility into areas which are inaccessible under normal operation, or where the operating ambience is not suitable for continuous real-time monitoring.

We routinely post information that may be important to investors in the Investors section of our website. For more information, please visit: https://www.odysight.ai or follow us on Twitter, LinkedIn and YouTube.

Backlog


We present our results of operations in a way that we believe will be the most meaningful and useful to investors, analysts, rating agencies and others who use our financial information to evaluate our performance. Backlog is presented for supplemental informational purposes only, and is not intended to be a substitute for any GAAP financial measures, including revenue or net income (loss), and, as calculated, may not be comparable to companies in other industries or within the same industry with similarly titled measures of performance. In addition, backlog should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. Therefore, backlog should be considered in addition to, not as a substitute for, or in isolation from, measures prepared in accordance with GAAP.

^1^Including cash, cash equivalentsand restricted cash.

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities Litigation Reform Act of 1995 relating to future events or our future performance. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements regarding long-term growth prospects. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology. Those statements are based on information we have when those statements are made or our management’s current expectation and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward- looking statements. Factors that may affect our results, performance, circumstances or achievements include, but are not limited to the following: (i) market acceptance of our existing and new products, including those that utilize our micro Odysight.ai technology or offer Predictive Maintenance and Condition Based Monitoring applications, (ii) lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of our products, (iv) intense competition in the medical device and related industries from much larger, multinational companies, (v) product liability claims, product malfunctions and the functionality of Odysight.ai’s solutions under all environmental conditions, (vi) our limited manufacturing capabilities and reliance on third-parties for assistance, (vii) an inability to establish sales, marketing and distribution capabilities to commercialize our products, (viii) an inability to attract and retain qualified personnel, (ix) our efforts obtain and maintain intellectual property protection covering our products, which may not be successful, (x) our reliance on a single customer that accounts for a substantial portion of our revenues, (xi) our reliance on single suppliers for certain product components, including for miniature video sensors which are suitable for our Complementary Metal Oxide Semiconductor technology products, (xii) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain, (xiii) the impact of computer system failures, cyberattacks or deficiencies in our cybersecurity, (xiv) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical, global supply chain and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction, including the adoption or expansion of economic sanctions, tariffs or trade restrictions and (xv) political, economic and military instability in Israel, including the impact of Israel’s war against Hamas, Hezbollah and Iran. These and other important factors discussed in Odysight.ai’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 26, 2025, and our other reports filed with the SEC, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Except as required under applicable securities legislation, Odysight.ai undertakes no obligation to publicly update or revise forward-looking information.

Company Contact:

Einav Brenner, CFO

info@odysight.ai

Investor Relations Contact:

Miri Segal

MS-IR LLC

msegal@ms-ir.com

Tel: +1-917-607-8654


ODYSIGHT.AI INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

Six months ended June 30, Three months ended June 30,
2025 2024 2025 2024
Unaudited
in thousands
REVENUES 1,368 362 1,181
COST OF REVENUES 1,077 229 667
GROSS PROFIT 291 133 514
RESEARCH AND DEVELOPMENT EXPENSES 2,975 2,356 1,408
SALES AND MARKETING EXPENSES 459 628 225
GENERAL AND ADMINISTRATIVE EXPENSES 2,585 1,587 1,245
OPERATING LOSS ) (5,728 ) (4,438 ) (2,364 )
FINANCING INCOME, NET 384 363 182
NET LOSS ) (5,344 ) (4,075 ) (2,182 )

All values are in US Dollars.

ODYSIGHT.AI INC.

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

December 31,<br> 2024
Audited
Assets
CURRENT ASSETS:
Cash and cash equivalents 18,164
Restricted cash -
Restricted deposit 322
Accounts receivable 1,510
Inventory 203
Other current assets 588
Total current assets 20,787
NON-CURRENT ASSETS:
Contract fulfillment assets 1,017
Property and equipment, net 407
Operating lease right-of-use assets 1,113
Severance pay asset 259
Other non-current assets 96
Total non-current assets 2,892
TOTAL ASSETS 23,679
Liabilities and shareholders’ equity
CURRENT LIABILITIES:
Accounts payable 442
Contract liabilities - short term 702
Operating lease liabilities - short term 539
Accrued compensation expenses 1,124
Related parties 120
Other current liabilities 368
Total current liabilities 3,295
NON-CURRENT LIABILITIES:
Contract liabilities - long term 1,373
Operating lease liabilities - long term 508
Liability for severance pay 259
Total non-current liabilities 2,140
TOTAL LIABILITIES 5,435
SHAREHOLDERS’ EQUITY:
Common stock, 0.001 par value; 300,000,000 shares authorized as of June 30, 2025 and December 31, 2024, 16,326,656 and 12,612,517 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively 13
Additional paid-in capital 64,205
Accumulated deficit ) (45,974
TOTAL SHAREHOLDERS’ EQUITY 18,244
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY 23,679

All values are in US Dollars.